High-Dollar Insider Sells - Zuckerberg Sells 41M Facebook Shares

Author's Avatar
Dec 27, 2013
Article's Main Image

Yesterday insider executives made large sells at Facebook Inc. (FB, Financial), United Therapeutics Corporation (UTHR, Financial) and Hillenbrand Inc. (HI, Financial), all companies held by billionaires. Here are the company updates and trade highlights.

Facebook Inc. (FB, Financial)

Up 123% over 12 months, Facebook Inc. has a market cap of $141.9 billion; its shares were traded at around $56.79 with a P/E ratio of 142.90 and P/S ratio of 22.12. The company does not pay a dividend.

Facebook Inc. is a social networking website that builds products that creates utility for users, developers, and advertisers. The company enables people who use Facebook to stay connected with their friends and family, to discover and share what is going on in the world around them. Developers use the Facebook Platform to build applications and websites that integrate with Facebook to reach its global network of users and to build products that are more personalized and social.

Facebook Inc. is a Delaware corporation, incorporated in July 2004.

Insider Action: Mark Zuckerberg, the COB and CEO, 10% Owner of Facebook Inc. (FB, Financial) sold 41,350,000 shares on Dec. 26, 2013, at an average price of $55.05. The total transaction amount is $2,276,317,468.

Check out the 10-Year Valuations.

The GuruFocus analysis shows two medium warning signs.

Guru Action: Here are numerous guru stakeholders and more insider selling.

Tracking historical share price, revenue and net income:

03May20171509331493842173.png

United Therapeutics Corporation (UTHR, Financial)

Up 115% over 12 months, United Therapeutics Corporation has a market cap of $5.62 billion; its shares were traded at around $113.10 with a P/E ratio of 20.30 and P/S ratio of 5.47. The company does not pay a dividend.

Incorporated in 1996, United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of products to address the medical needs of patients with chronic and life-threatening conditions. The company operates two business segments: pharmaceuticals and telemedicine.

Insider Action: The CEO of United Therapeutics Corporation (UTHR, Financial) Martine A. Rothblatt sold 21,981 shares on Dec.26, 2013, at an average price of $111.95. The total transaction amount is $2,460,773.

Check out the 10-Year Valuations.

The GuruFocus analysis shows two medium warning signs and one good sign.

Guru Action: Here are four guru stakeholders and more insider selling.

Tracking historical share price, revenue and net income:

03May20171509331493842173.png

Hillenbrand Inc. (HI, Financial)

Up 31% over 12 months, Hillenbrand Inc. has a market cap of $1.84 billion; its shares were traded at around $29.25 with a P/E ratio of 28.90 and P/S ratio of 1.18. The dividend yield of Hillenbrand Inc. stocks is 2.69%. Hillenbrand Inc. had an annual average earnings growth of 0.40% over the past 5 years.

Incorporated in 2007, Hillenbrand manufactures and supplies burial caskets, cremation products, and related services to licensed funeral homes with its two business platforms: the Process Equipment Group and Batesville. The company’s process equipment group is a recognized leader in the design, production, marketing and servicing of equipment and systems used in processing applications for a wide range of industrial markets like plastics, food, chemicals, pharmaceuticals, power generation, coal mining, pulp and paper, frac sand, industrial minerals, agribusiness, recycling, wood and forest products, and biomass energy generation.

Insider Action: The Senior Vice President and CFO of Hillenbrand Inc. (HI, Financial) Cynthia L. Lucchese sold 49,419 shares on Dec. 26, 2013, at an average price of $29. The total transaction amount is $1,433,151.

Guru Action: Here are more guru stakeholders and insiders trading HI.

Check out the 10-Year Valuations.

The GuruFocus analysis shows seven warning signs.

Tracking historical share price, revenue and net income:

03May20171509341493842174.png

Use the GuruFocus special feature screen to find more insider trades.

GuruFocus Real Time Picks reports the stock purchases and sales that Gurus have made within the prior 2 weeks. The report time lag can be as short as 2 days after the date of the transaction. This feature is for Premium Members only.

If you are not a Premium Member, we invite you for a 7-day Free Trial.